WWP1 and breast cancer: WWP1 may also influence PI3K/AKT signaling through PTEN-independent mechanisms, as evidenced by Wang et al.'s finding that WWP1 overexpression activates the PI3K/AKT pathway and reduces BC sensitivity to paclitaxel without significantly altering PTEN protein levels (Wang L. et al., 2021).